[HTML][HTML] IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation

…, L Preisser, S Blanchard, E Garo, E Hoppe… - 2012 - journals.plos.org
Interleukin-26 (IL-26), a member of the IL-10 cytokine family, induces the production of
proinflammatory cytokines by epithelial cells. IL-26 has been also reported overexpressed in …

Sex hormone-binding globulin in osteoporosis

E Hoppé, B Bouvard, M Royer, M Audran, E Legrand - Joint bone spine, 2010 - Elsevier
Sex hormone-binding globulin (SHBG) is a plasma glycoprotein that binds with high affinity
to sex steroids, most notably 5α-dihydrotestosterone, testosterone, and 17β-estradiol, …

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study

…, A Martin, E Brénaut, E Hoppé… - Journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
… 14 , Emmanuel Hoppé … 17 , Emmanuel Delaporte …

Rheumatic and musculoskeletal features of Whipple disease: a report of 29 cases

M Meunier, X Puechal, E Hoppé, M Soubrier… - The Journal of …, 2013 - jrheum.org
Objective. Whipple disease is a rare infection caused by Tropheryma whipplei. Although
patients commonly complain of osteoarticular involvement, musculoskeletal manifestations …

Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic …

C Masson, V Simon, E Hoppé, P Insalaco, I Cissé… - Joint Bone Spine, 2004 - Elsevier
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is an autosomal
dominant inherited condition of periodic fever and pain. Most patients are of northern European …

[HTML][HTML] High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy

B Bouvard, E Hoppé, P Soulie, M Georgin-Mege… - Annals of oncology, 2012 - Elsevier
Background The purpose of this study was to describe bone status in a large cohort of
postmenopausal women with nonmetastatic breast cancer, at the initiation of aromatase inhibitor …

[HTML][HTML] Fracture incidence after 3 years of aromatase inhibitor therapy

B Bouvard, P Soulié, E Hoppé, M Georgin-Mege… - Annals of oncology, 2014 - Elsevier
Background The purpose of this study was to describe the fracture incidence and bone mineral
density (BMD) evolution in a large cohort of post-menopausal women with breast cancer …

Whipple's disease diagnosed during biological treatment for joint disease

E Hoppé, C Masson, M Audran, M Drillon, M Andreu… - Joint Bone Spine, 2010 - Elsevier
OBJECTIVES: Increased susceptibility to infections is among the main safety concerns
raised by biological agents. We describe five cases of Whipple's disease diagnosed during …

[HTML][HTML] Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance

JM Piot, M Royer, A Schmidt-Tanguy, E Hoppé… - Blood cancer …, 2015 - nature.com
Monoclonal gammopathies of undetermined significance (MGUS) have been shown to be
associated with an increased risk of fractures. This study describes prospectively the bone …

[HTML][HTML] Osteoporosis treatment and 10 years' oestrogen receptor+ breast cancer outcome in postmenopausal women treated with aromatase inhibitors

B Bouvard, J Chatelais, P Soulié, E Hoppé… - European journal of …, 2018 - Elsevier
Background Risk factors for breast cancer relapse are well-known, such as large tumour
size or lymph node involvement. The aim of our study was to analyse the influence of bone …